Evidence map›Paper›PMID 32708787›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis and Evaluation of New Coumarin Derivatives as Antioxidant, Antimicrobial, and Anti-Inflammatory Agents.

Hanan M Alshibl, Ebtehal S Al-Abdullah, Mogedda E Haiba, Hamad M Alkahtani, Ghada E A Awad, Ahlam H Mahmoud, Bassant M M Ibrahim, Ahmed Bari, Alexander Villinger

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. In Vitro Safety and Efficacy Evaluation of aPlants (Basel, Switzerland) · 2024
    Article
  19. Coumarin: A natural solution for alleviating inflammatory disorders.Current research in pharmacology and drug discovery · 2024
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hanan M AlshiblDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-0150-8434
Ebtehal S Al-AbdullahDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Mogedda E HaibaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Hamad M AlkahtaniDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-6983-8587
Ghada E A AwadChemistry of Natural and Microbial Product Department, National Research Centre, Cairo 12622, Egypt.
Ahlam H MahmoudDepartment of Therapeutic Chemistry, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, Cairo 12622, Egypt.
Bassant M M IbrahimPharmacology Department, Medical Research Division, National Research Centre, Cairo 12622, Egypt.ORCID 0000-0003-4668-9811
Ahmed BariDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Alexander VillingerInstitut für Chemie, Abteilung Anorganische Chemie, Universität Rostock, Albert-Einstein-Str. 3a, 18059 Rostock, Germany.

Funding

Female Center for Scientific and Medical Colleges, King Saud University 00
6 · The paper itself

Abstract

New pyranocoumarin and coumarin-sulfonamide derivatives were prepared and evaluated for their antioxidant, antimicrobial, and/or anti-inflammatory activities. Coumarin-sulfonamide compounds

Indexed as

AnimalsAnti-Infective AgentsAnti-Inflammatory AgentsAntioxidantsCoumarinsEdemaFormaldehydeHumansMolecular StructureRatsStructure-Activity RelationshipAnti-Infective AgentsAnti-Inflammatory AgentsAntioxidantscoumarinCoumarinsFormaldehydeanti-inflammatoryantimicrobialantioxidantcoumarinpyranocoumarinsulfonamidesynthesis

Identifiers

PMID32708787
PMCPMC7397269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.